- Conditions
- Anorexia, Body Weight, Body Weight Changes, +18 more
- Locations
-
- CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
Clinical trial condition
Signs and Symptoms, Digestive
Explore clinical trials studying Signs and Symptoms, Digestive. Study availability and eligibility vary by location and protocol.
3,789 public trials
399 recruiting studies
Signs and Symptoms, Digestive trial results
NCT01586806
- Conditions
- Anterior Cruciate Ligament Reconstruction, Nausea, Neurologic Manifestations, +6 more
- Locations
-
- Hospital for Special Surgery New York, United States
Completed
Perineal Self-Acupressure
NCT01867944
- Conditions
- Cardiovascular Diseases, Chronic Constipation, Constipation, +9 more
- Locations
-
- UCLA Center for East-West Medicine Los Angeles, California, United States
Completed
A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome
NCT00368771
- Conditions
- Abdominal Pain, Colonic Diseases, Colonic Diseases, Functional, +11 more
- Locations
-
Not specified
Completed
Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
NCT00232089
- Conditions
- Dyspepsia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, +1 more
- Locations
-
- Novartis East Hanover, New Jersey, United States
NCT02252822
- Conditions
- Eating Disorders, Feeding and Eating Disorders, Mental Disorders, +3 more
- Locations
-
- Capital Health District Health Authority Halifax, Nova Scotia, Canada
NCT00382772
- Conditions
- Diarrhea, Infections, Infections, Rotavirus, +7 more
- Locations
-
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Helsinki, Finland
- GSK Investigational Site Jarvenpaa, Finland
NCT00334607
- Conditions
- Diarrhea, Infections, Infections, Rotavirus, +7 more
- Locations
-
- GSK Investigational Site Benton, Arkansas, United States
- GSK Investigational Site Cabot, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
- GSK Investigational Site Little Rock, Arkansas, United States
- Conditions
- Nausea, Neurologic Manifestations, Pain, +4 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
NCT01780428
- Conditions
- Nausea, Neurologic Manifestations, Pain, +4 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States